Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase.

EClinicalMedicine · 2024 · PMC11245995 · PMID 39007060

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

Analysis of the diagram revealed a notable trend that SPMs originating from leukemia predominantly aligned with HMs rather than solid tumors.

also in 2,380 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.